In agreement with the in vitro results, western blot experiments revealed a suppression of Bcl-2 expression, accompanied with an increasing of Bax expression in melanomas treated with dA, leading to a raise in the Bax/Bcl-2 ratio as shown in Fig. 5d and Supplementary Fig. 5a. Here, BAX is linked to melanoma.